Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2021-12-13 2021-12-13
Drug Identification Number 02225158 02225158
Brand name SUPREFACT SUPREFACT
Common or Proper name Buserelin Buserelin
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients BUSERELIN BUSERELIN
Strength(s) 100MCG 100MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration NASAL NASAL NASAL NASAL
Packaging size 10ml Spray 10ml Spray
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2021-05-31 2021-05-31
Remaining supply date 2021-05-31 2021-05-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments